Carotid stenosis and coronary artery bypass grafting

Marcelo Pereira da Rosa1, Vera Lúcia Portal

  • 1Instituto de Cardiologia, Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil. verap.pesquisa@cardiologia.org.br

Revista Da Associacao Medica Brasileira (1992)
|June 22, 2011
PubMed

Insights

Carotid stenosis (CS) affects 17.4% of patients undergoing coronary artery bypass grafting (CABG). Clinically relevant CS and chronic renal failure (CRF) independently predict mortality in these patients.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Nephrology

Background:

  • Coronary artery bypass grafting (CABG) is a common procedure.
  • Carotid stenosis (CS) is a potential comorbidity in patients undergoing CABG.
  • Identifying risk factors for mortality in CABG patients is crucial.

Purpose of the Study:

  • To determine the prevalence of carotid stenosis (CS) in patients scheduled for elective coronary artery bypass grafting (CABG).
  • To identify independent predictors of mortality among these patients.

Main Methods:

  • A cohort study included 393 patients undergoing scheduled CABG.
  • Carotid arteries were assessed for stenosis using color Doppler ultrasound prior to CABG.
  • Morbidity and mortality were tracked during hospitalization.
  • Logistic regression analysis was employed to identify independent predictors of mortality.

Main Results:

  • The prevalence of carotid stenosis (CS) was 17.4%.
  • Clinically relevant CS (defined as >50% stenosis) was a significant independent predictor of mortality (p = 0.001).
  • Chronic renal failure (CRF) was also identified as an independent predictor of mortality (p = 0.03).

Conclusions:

  • Carotid stenosis (CS) is highly prevalent in patients undergoing CABG.
  • Both CS (>50%) and chronic renal failure (CRF) are independent predictors of mortality in this patient population.
  • These findings highlight the importance of assessing for CS and CRF in CABG candidates.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
The Arch of Aorta01:10

The Arch of Aorta

The coronary arteries, originating from the ascending aorta, bifurcate from two sinuses located within the ascending aorta. Positioned just above the aortic semilunar valve, these sinuses house essential aortic baroreceptors and chemoreceptors, crucial for maintaining cardiac function. The left coronary artery and the right coronary artery branch off from the left posterior and anterior aortic sinuses, respectively.
Encircling the heart, the coronary arteries form a ring-like structure before...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...